常壓氧療法干預對大鼠腦缺血再灌注損傷的保護作用及其機制研究
[Abstract]:Background cerebrovascular disease is a kind of disease which is caused by the impairment of blood circulation in the blood vessels of the brain. It is mainly divided into two types of ischemic and hemorrhagic diseases, which are mainly acute cerebral vascular diseases. As one of the most common and serious diseases threatening human life and health in the world, the incidence of cerebrovascular diseases is high and death is high. High death rate, data show that about 15 million people all over the world die of the disease every year, the leading cause of all kinds of death. Ischemic cerebrovascular disease (Ischemic cerebrovascular disease, ICVD) refers to the insufficiency or interruption of cerebral ischemia and hypoxia caused by the occlusion or stenosis of the arteries supplying the blood of the brain, which eventually leads to the local brain. The effective method is to carry out reperfusion and restore the blood circulation in the ischemic area by thrombolytic or mechanical dredging. But in many cases, after reperfusion, the brain not only does not restore the function, but further aggravates the structure and function of the brain tissue. It is called Cerebral ischemia-reperfusion injury (CIRI). The pathological process and mechanism of cerebral ischemia reperfusion injury is very complicated. This process is a rapid cascade reaction involving multiple links, including the activation of apoptosis genes, the release of excitatory amino acids, and the homeostasis of intracellular calcium ions. There is an obstacle in energy metabolism and the formation of free radicals. These links are closely linked, overlapping and cause and effect, forming a vicious cycle, which eventually leads to the necrosis or apoptosis of the brain cells. In view of the complex pathophysiological mechanism of CIRI, there have been significant advances in research, but the effective treatment methods are still limited and many studies have been studied. People want to be treated with drugs. One idea is to use thrombolytic drugs such as the recombinant recombinant tissue plasminogen activator (RTPA), but it has a risk of causing bleeding and aggravating damage. Another idea is to use neuroprotectant, the key ring of cascade reaction after ischemia. Normobaric oxygen therapy (NOT), also known as the normal pressure and high concentration oxygen therapy, refers to the use of specific oxygen inhalation devices in the ambient pressure ring, which is made under non pressure conditions. In recent years, many studies have shown that the treatment of acute ischemia reperfusion injury model in rats by atmospheric pressure oxygen therapy can reduce the infarct volume in the brain tissue of the model rats and reduce the brain edema and inflammation, and can be used to rescue the acute cerebral ischemia tissue. How to effectively protect the brain tissue of acute ischemia-reperfusion injury is an urgent problem and need to be further studied. Objective to deal with the model of cerebral ischemia reperfusion injury in acute rats by atmospheric pressure oxygen therapy, and discuss the normal pressure from the level of behavior, histology and cell molecular biology. The protective effect of oxygen therapy on focal cerebral ischemia reperfusion injury in rats and its possible mechanism provide the basis for finding a clinical method for effective treatment of CIRI. Methods 5 models of sham operation group and 10 rat models of cerebral ischemia-reperfusion injury were prepared by modified linear embolization method, and the model rats were evaluated according to the standard of Zea-Longa. 70 healthy male SD rats of the same month age were randomly divided into sham operation group, cerebral ischemia reperfusion model group, group NOT 3h, group 6h, group 9h, group 9h, 12h group, 24h group, and the sham operation group only ligation of the common carotid artery and the external carotid artery, and the cerebral ischemia reperfusion model group was in the brain deficiency. After the blood 1.5h was pulled out to carry out the blood flow reperfusion 24h, the rest of the other groups were placed in the self-made closed atmospheric high oxygen supply device after cerebral ischemia 1.5h and placed in the self-made high oxygen supply device of closed atmospheric pressure. The rats were treated with 3h, 6h, 9h, 12h, 24h, and the rats were placed in the air at the end of the corresponding oxygen supply time. The brain tissue was taken out and the volume and water content of cerebral infarction were measured in each group. The changes of Superoxide dismutase (SOD) activity and the content of malondialdehyde (Malondialdehyde, MDA) were detected in the homogenate of each group, and the methods of real-time fluorescence quantitative PCR (quantitative Real-time PCR, qRT-PCR) were used to detect each group. The changes in the transcription and expression of inflammatory factors TNF- alpha and IL- beta 1 in the rat brain tissue, and the changes in the expression of TNF- alpha and IL- beta 1 in brain tissues by enzyme linked immunosorbent assay (Euzyme linked immunosorbent assay, ELISA) and Western blot (Western blot, WB). Results 1, the scores of neurological deficits of 5 rats in the sham operation group were 0 scores. In the 10 rats of the model group, the symptoms of the lateral front claw could not be fully extended, to the opposite side of the dump or turn circle. The score was significantly different from the sham group (P=0.000). It showed that the model group had been injured, the model was successful.2, and the scores of the neural functional defects in the sham operation group were all O points, compared with the sham operation group, the scores of the other groups were significantly higher than those in the sham operation group. In addition to the model group, compared with the model group, the NOT 3H group and the 6h group scored significantly lower P0.05), the difference was statistically significant.3. Except for the sham operation group, the other groups had different degrees of cerebral infarction, the degree was different. Compared with the model group, the NOT 3H group, the 6h group and the 9h group were significantly smaller, the water content decreased significantly (P0.05), the difference was significant, NOT was significant, the difference was significant, the difference was significant. Compared with the sham group, the SOD activity of the other groups was significantly decreased and the MDA content was significantly increased (P0.05). Compared with the model group, the SOD activity of the NOT 3H group and the 6h group was significantly higher than that in the sham group. Compared with the model group, the SOD activity of the NOT 3H group and the 6h group was significantly increased, and the MDA content was significantly reduced (0.05). Compared with the sham group, the SOD activity was significantly reduced (0.05), and the other groups were transcribed with 1 transcripts compared with the sham operation group. The level of two inflammatory factors in NOT 3H group, 6h group and 9h decreased, and NOT 6h group decreased most significantly (P0.05).6, and ELISA and wB showed that the expression level of TNF- alpha and beta 1 protein in each group was higher than that of the artificial hand group. Compared with the model group, the two inflammatory factors were compared with the model group. The decrease is most significant (P0.05). Conclusion atmospheric oxygen therapy has a protective effect on acute cerebral ischemia-reperfusion injury in rats. The different time points and duration of NOT treatment have a very important effect on the protective effect of cerebral ischemia-reperfusion injury. The application of reperfusion in ischemic 1.5h and the intervention of NOT to 3H to 9h have a certain therapeutic effect. Effect, and intervention in the best effect of 3-6h. Atmospheric oxygen therapy for the treatment of CIRI may be by reducing the oxidative stress stimulation in the brain damage area and down-regulation of the expression of proinflammatory factors, which provides a certain basis for clinical treatment of CIRI.
【學位授予單位】:新鄉(xiāng)醫(yī)學院
【學位級別】:碩士
【學位授予年份】:2015
【分類號】:R743.3
【參考文獻】
相關期刊論文 前10條
1 曹秋云,江開達,潘旭東;大鼠腦缺血再灌注損傷IL-8變化的研究[J];放射免疫學雜志;2001年02期
2 范瑞明;余昌胤;楊麗;詹劍;;糖尿病大鼠缺血再灌注腦組織核轉(zhuǎn)錄因子-κB的表達及意義[J];貴州醫(yī)藥;2006年11期
3 高艷;;小膠質(zhì)細胞生理特點及在腦缺血損傷中的作用[J];中國組織化學與細胞化學雜志;2012年06期
4 田士強,王任直,李桂林,王欣,張波,姚勇,竇萬臣,孔燕國;大鼠局灶性腦缺血模型的改進[J];基礎醫(yī)學與臨床;2004年04期
5 韓英,劉楠,陳榮華,鄭安,黃華品;白細胞介素8在大鼠腦缺血再灌注損傷中的變化[J];中國動脈硬化雜志;2005年02期
6 冷耀明;毛衛(wèi)未;殷小平;詹忠明;方歡歡;蔣欽;;糖尿病腦梗死患者血清IL-18、MMP-9水平與腦缺血損傷的關系[J];山東醫(yī)藥;2010年17期
7 狄政莉,萬琪,來華安,王洪典;IL-1β和IL-6在腦缺血再灌注微血管內(nèi)皮細胞炎癥反應中的作用[J];西安醫(yī)科大學學報;2001年05期
8 張紅星;劉靈光;周利;黃浩;李璇;楊敏;;頭針對急性腦缺血再灌注大鼠炎癥反應的影響[J];中西醫(yī)結合學報;2007年06期
9 吳建華;方云祥;;法舒地爾對大鼠腦缺血再灌注損傷炎癥反應的影響[J];中國臨床藥理學與治療學;2008年04期
10 方舒東;朱也森;;腦缺血再灌注損傷的病理生理研究進展[J];醫(yī)學綜述;2006年18期
,本文編號:2154865
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2154865.html